Phase I trial of remimazolam to assess the abuse potential
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Adverse reactions
- 14 Nov 2017 According to a PAION media release, recruitment of this trial was completed in the second quarter of 2017.
- 14 Nov 2017 Status changed from recruiting to active, no longer recruiting, according to a PAION media release.
- 09 Aug 2017 According to a PAION media release, part 1 with twelve subject successfully completed.